DISCOVER A
NEW PILL DESIGNED
TO PREVENT MIGRAINE DAYS AND KEEP THEM AWAY OVER TIME

Meet people who prevented migraine days with QULIPTA™

QULIPTA™ is a pill that significantly reduced monthly migraine days across 12 weeks in clinical studies

QULIPTA (atogepant) is a prescription medicine used for the preventive treatment of episodic migraine in adults.

QULIPTA Complete Savings Card
QULIPTA Complete Savings Card

SAVINGS AND SUPPORT MADE SIMPLE

Enroll today and learn how you could save on the cost of QULIPTA.*

*Terms and Conditions apply. This benefit covers QULIPTA™ (atogepant). Eligibility: Available to patients with commercial prescription insurance coverage for QULIPTA who meet eligibility criteria. The program is not available to cash-paying patients or patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the QULIPTA Complete Savings Card and patient must call 1.855.QULIPTA to stop participation. Under this program, an eligible patient whose insurer has imposed coverage restrictions that have not been satisfied may receive up to a maximum of two 30-day fills at no charge for an FDA approved indication while coverage is pending. This payment may not be applied towards any out-of-pocket limits or other deductibles under patient’s insurance coverage. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from QULIPTA Complete from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This assistance offer is not health insurance. By redeeming this card, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html.

IMPORTANT SAFETY INFORMATION

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

  • Have kidney problems or are on dialysis
  • Have liver problems
  • Are pregnant or plan to become pregnant. It is not known if QULIPTA will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if QULIPTA passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking QULIPTA

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines.

The most common side effects of QULIPTA are nausea, constipation, and fatigue. These are not all the possible side effects of QULIPTA.

What is QULIPTA?

QULIPTA (atogepant) is a prescription medicine used for the preventive treatment of episodic migraine in adults.

Please see full Patient Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.

Important Safety Information

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

Important Safety Information

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

Important Safety Information

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

Important Safety Information

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

IMPORTANT SAFETY INFORMATION

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

  • Have kidney problems or are on dialysis
  • Have liver problems
  • Are pregnant or plan to become pregnant. It is not known if QULIPTA will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if QULIPTA passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking QULIPTA

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines.

The most common side effects of QULIPTA are nausea, constipation, and fatigue. These are not all the possible side effects of QULIPTA.

What is QULIPTA?

QULIPTA (atogepant) is a prescription medicine used for the preventive treatment of episodic migraine in adults.

Please see full Patient Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.